rRp450

AXP000088.1 · Oncolytic virus

Platform
HSV-1 (KOS strain, ICP6-replaced)
Originator
Nationwide Children's Hospital / The Ohio State University
Sponsor
Nationwide Children's Hospital

Names

NameTypeSource
rRp450preferred name, codecurator, ncit

Virus

Role
Oncolytic
Family
Orthoherpesviridae
Virus
herpes simplex virus 1 (NCBI Taxonomy 10298)
Strain
KOS
Replication
conditionally replicating
Modifications
UL39 (ICP6) replaced by the rat CYP2B1 gene; gamma34.5 intact
Transgenes
CYP2B1 (rat)
Route
intra arterial
Source
evidence

Cross-references

NCI Thesaurus
C90563

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT01071941rRp450-Phase I Trial in Liver Metastases and Primary Liver TumorsTerminatedPhase 12010-102024-0615Liver Metastases; Primary Liver Cancers

Recent changes

No changes recorded in its trials yet.

Clinical papers

No confirmed clinical papers yet.

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 30505937Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment.Molecular therapy oncolytics2018name in abstract: rRp450
PMID 28649600Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors.Molecular therapy oncolytics2017name in title: rRp450
PMID 18388918Efficacy and safety of the oncolytic herpes simplex virus rRp450 alone and combined with cyclophosphamide.Molecular therapy : the journal of the American Society of Gene Therapy2008name in title: rRp450
PMID 12209705Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene.Cancer2002name in abstract: rRp450
PMID 11221871Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconversion by a replicating oncolytic viral vector.Cancer research2001name in abstract: rRp450
PMID 10850415Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpesvirus.Cancer research2000name in abstract: rRp450
PMID 10933953Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas.Molecular therapy : the journal of the American Society of Gene Therapy2000name in abstract: rRp450
PMID 10463570Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies.Cancer research1999name in abstract: rRp450

NIH grants

ProjectTitleOrganisationPIYearsLinked by
26120080000DCTD Biopharmaceutical DevelopmentLEIDOS BIOMEDICAL RESEARCH, INC.HEIMBROOK, DAVID2008–2018name in abstract: rRp450
R01CA114004Oncolytic HSV Therapy in Immunocompetent Sarcoma ModelsCINCINNATI CHILDRENS HOSP MED CTRCRIPE, TIMOTHY P2006–2010name in abstract: rRp450
N01CO12400-DCTD Biopharmaceutical Development 2007–2007name in abstract: rRp450
R21CA119600Phase I clinical trial of viral oncolysis of liver tumo*MASSACHUSETTS GENERAL HOSPITALTANABE, KENNETH K2006–2007name in abstract: rRp450

Notes

ICP6 replaced by rat CYP2B1, which converts cyclophosphamide to its active metabolite. Phase 1 in primary and metastatic liver tumours (NCT01071941); dosing route and final enrolment not re-verified from a primary report.

How to cite

rRp450 (AXP000088.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000088.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.